[1]
H. Riza, A. Fahrurroji, A. Wicaksono, A. K. Nugroho, and S. Martono, “DOCKING STUDY OF METHYL HESPERIDIN AS NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR”, Int J Pharm Pharm Sci, vol. 10, no. 3, pp. 85–89, Mar. 2018.